Health Industry

Latest KFF Health News Stories

Hospitals’ Best-Laid Plans Upended By Disaster

KFF Health News Original

An onslaught of fires, shootings and storms across the country last year tested hospital readiness. Now, leaders are using their experiences to address shortcomings that surfaced amid the chaos.

University Under Fire For Off-The-Grid Herpes Vaccine Experiments

KFF Health News Original

Southern Illinois University’s medical school has halted all herpes research, one of its most high-profile projects, amid growing controversy over a researcher’s unauthorized methods offshore and in the U.S.

Judge Orders New Olympus Trial Over Superbug Death

KFF Health News Original

The Seattle jurist finds that Olympus Corp. failed to properly disclose evidence that it knew of concerns about cleaning problems with its redesigned medical scopes years before they hit the market and were linked to dozens of deaths. The company maintains the devices were not defective and intends to appeal.

Podcast: What The Health? Our First Live Show: What The Health Will Happen In 2018?

KFF Health News Original

In this episode of “What The Health?” — taped before a live audience — panelists discuss the potential federal government shutdown and what may be in store for health in 2018. They are joined by former Medicare and Medicaid head Tom Scully.

Facebook Live: It’s 2018, Can Big Pharma Hold The Line Against Pricing Controls?

KFF Health News Original

In this chat, KHN senior correspondent Jay Hancock discusses how drug-pricing battles could play out this year in D.C., state legislatures and beyond. What do we know about the drug industry’s agenda to quiet the drumbeat of cost control and transparency proposals? How will they officials target their efforts? Will the battles take place at the state level? Senior editor Stephanie Stapleton moderates.

Pharmacists Slow To Dispense Lifesaving Overdose Drug

KFF Health News Original

Laws in California and most other states allow pharmacists to provide naloxone to patients or their friends without a doctor’s prescription. But many don’t do so, citing lack of demand and awareness among patients, their own fears of insufficient compensation and the challenges of treating opioid users.